Lifevantage PE Ratio 2010-2024 | LFVN

Current and historical p/e ratio for Lifevantage (LFVN) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Lifevantage PE ratio as of December 20, 2024 is 29.55.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Lifevantage PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-12-20 17.36 54.25
2024-09-30 12.05 $0.32 37.65
2024-06-30 6.37 $0.23 27.71
2024-03-31 5.97 $0.28 21.34
2023-12-31 5.90 $0.23 25.63
2023-09-30 6.30 $0.20 31.51
2023-06-30 3.99 $0.20 19.95
2023-03-31 3.27 $-0.06 0.00
2022-12-31 3.36 $-0.05 0.00
2022-09-30 3.36 $0.04 84.02
2022-06-30 3.87 $0.24 16.12
2022-03-31 4.20 $0.70 6.00
2021-12-31 5.58 $0.73 7.64
2021-09-30 5.98 $0.98 6.10
2021-06-30 6.49 $0.90 7.21
2021-03-31 8.25 $0.81 10.19
2020-12-31 8.23 $0.80 10.29
2020-09-30 10.66 $0.84 12.69
2020-06-30 11.94 $0.79 15.11
2020-03-31 9.09 $0.79 11.51
2019-12-31 13.78 $0.80 17.23
2019-09-30 12.10 $0.56 21.60
2019-06-30 11.46 $0.50 22.92
2019-03-31 12.62 $0.45 28.04
2018-12-31 11.64 $0.45 25.88
2018-09-30 9.70 $0.41 23.66
2018-06-30 5.62 $0.41 13.72
2018-03-31 3.19 $0.21 15.18
2017-12-31 4.20 $0.09 46.69
2017-09-30 3.73 $0.09 41.40
2017-06-30 3.82 $0.11 34.75
2017-03-31 4.74 $0.26 18.23
2016-12-31 7.20 $0.33 21.80
2016-09-30 8.35 $0.42 19.89
2016-06-30 12.01 $0.42 28.59
2016-03-31 8.03 $0.26 30.90
2015-12-31 8.40 $0.26 32.33
2015-09-30 5.01 $0.22 22.75
2015-06-30 3.28 $0.49 6.69
2015-03-31 4.88 $0.63 7.75
2014-12-31 8.03 $0.70 11.48
2014-09-30 7.05 $0.84 8.39
2014-06-30 8.90 $0.70 12.72
2014-03-31 8.10 $0.56 14.46
2013-12-31 10.20 $0.63 16.19
2013-09-30 14.71 $0.42 35.04
2013-06-30 14.34 $0.42 34.15
2013-03-31 14.52 $0.70 20.75
2012-12-31 13.53 $0.14 96.67
2012-09-30 21.20 $0.49 43.27
2012-06-30 17.49 $0.42 41.64
2012-03-31 23.24 $-3.78 0.00
2011-12-31 8.84 $-4.34 0.00
2011-09-30 9.27 $-4.27 0.00
2011-06-30 9.27 $-4.34 0.00
2011-03-31 4.39 $-0.98 0.00
2010-12-31 2.41 $-1.05 0.00
2010-09-30 3.09 $-1.54 0.00
2010-06-30 3.15 $-1.47 0.00
2010-03-31 2.41 $-1.75 0.00
2009-12-31 1.55 $-1.54 0.00
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.222B $0.200B
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.526B 20.06
Becton Dickinson (BDX) United States $64.714B 17.01
Cardinal Health (CAH) United States $28.315B 15.35
West Pharmaceutical Services (WST) United States $23.683B 48.37
Labcorp (LH) United States $18.984B 15.74
Cooper (COO) United States $18.348B 24.85
Align Technology (ALGN) United States $15.944B 30.51
Henry Schein (HSIC) United States $8.597B 16.38
Merit Medical Systems (MMSI) United States $5.611B 28.65
DENTSPLY SIRONA (XRAY) United States $3.671B 9.98
Patterson (PDCO) United States $2.730B 14.58
CONMED (CNMD) United States $2.162B 18.04
STAAR Surgical (STAA) United States $1.231B 45.42
Pro-Dex (PDEX) United States $0.151B 30.10